Nick Daneman Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

1/2023	Nursing home crowding and its association with outbreak-associated respiratory infection in Ontario, Canada before the COVID-19 pandemic (2014-19): a retrospective cohort study.
8/2021	Regional variation in the potentially inappropriate first-line use of fluoroquinolones in Canada as a key to antibiotic stewardship? A drug utilization review study.
4/2021	Long-term macrolide therapy for chronic obstructive pulmonary disease: a population-based time series analysis.
6/2020	Defining appropriate antibiotic prescribing in primary care: A modified Delphi panel approach.
1/2019	Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study.
1/2017	Inhaled Long-acting Anticholinergics and Urinary Tract Infection in Individuals with COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nick Daneman Research Topics

Disease

50	Infections 05/2024 - 06/2009
32	Sepsis (Septicemia) 12/2023 - 01/2011
28	COVID-19 05/2024 - 10/2020
18	Critical Illness (Critically Ill) 10/2023 - 01/2011
16	Urinary Tract Infections (Urinary Tract Infection) 05/2024 - 12/2011
16	Communicable Diseases (Infectious Diseases) 08/2023 - 06/2011
16	Bacteremia 01/2023 - 04/2008
11	Clostridium Infections 01/2021 - 04/2012
10	Pneumonia (Pneumonitis) 06/2023 - 04/2008
8	Bacterial Infections (Bacterial Infection) 08/2023 - 04/2013
6	Soft Tissue Infections 06/2023 - 01/2011
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2017
4	Intraabdominal Infections 06/2023 - 01/2011
4	Coinfection 01/2023 - 04/2015
4	Burns 01/2021 - 11/2013
3	Neoplasms (Cancer) 09/2023 - 01/2020
3	Dementia (Dementias) 09/2023 - 10/2017
3	Pyelonephritis 08/2023 - 01/2011
3	Drug-Related Side Effects and Adverse Reactions 02/2023 - 12/2011
3	Sinusitis 08/2021 - 04/2020
3	Hypersensitivity (Allergy) 11/2020 - 08/2015
3	Ulcer 07/2017 - 04/2012
3	Ventilator-Associated Pneumonia 07/2017 - 05/2014
2	Respiratory Tract Infections (Respiratory Tract Infection) 07/2022 - 11/2021
2	Shock 01/2021 - 10/2020
2	Herpes Zoster 01/2021 - 01/2020
2	Common Cold 06/2020 - 04/2020
2	Bronchitis 06/2020 - 04/2020
2	Gastroenteritis 06/2020 - 08/2015
2	Frailty 10/2017 - 09/2017
2	Hemorrhage 07/2017 - 11/2016
2	Cross Infection (Nosocomial Infection) 11/2015 - 06/2011
2	Bacteriuria 10/2014 - 04/2014
1	Abscess 11/2023
1	Pyogenic Liver Abscess 11/2023
1	Cholangitis 08/2023
1	Neutropenia 01/2023
1	Cystic Fibrosis (Mucoviscidosis) 01/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Heart Failure 01/2023
1	Ileus 12/2021

Drug/Important Bio-Agent (IBA)

81	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 04/2008
6	FluoroquinolonesIBA 04/2023 - 11/2015
6	Ciprofloxacin (Cipro)FDA LinkGeneric 11/2022 - 07/2008
5	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 09/2023 - 09/2015
5	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 01/2017
5	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2023 - 11/2018
4	Meropenem (Merrem)FDA LinkGeneric 11/2022 - 09/2015
3	boldenone undecylenate (Equipoise)IBA 03/2024 - 02/2018
3	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2023 - 12/2011
3	Vancomycin FDA LinkGeneric 01/2023 - 07/2011
3	Ceftazidime (Fortum)FDA LinkGeneric 11/2022 - 09/2015
3	Oxygen (Dioxygen)IBA 11/2021 - 11/2013
3	MacrolidesIBA 04/2021 - 04/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2017 - 09/2008
2	LactamsIBA 04/2023 - 09/2015
2	AminoglycosidesIBA 02/2023 - 01/2019
2	Carbapenems (Carbapenem Antibiotics)IBA 02/2023 - 11/2018
2	SulfonamidesIBA 02/2023 - 10/2020
2	beta-LactamsIBA 02/2023 - 10/2016
2	Tobramycin (Nebcin)FDA LinkGeneric 11/2022 - 07/2014
2	Gentamicins (Gentamicin)FDA LinkGeneric 11/2022 - 01/2019
2	Amoxicillin (Wymox)FDA LinkGeneric 07/2022 - 11/2015
2	CoagulaseIBA 01/2022 - 01/2013
2	AcidsIBA 01/2021 - 06/2010
2	VaccinesIBA 01/2021 - 11/2016
2	ProcalcitoninIBA 01/2021 - 04/2015
2	Nitrofurantoin (Macrodantin)FDA LinkGeneric 10/2020 - 12/2011
2	Proton Pump InhibitorsIBA 07/2017 - 11/2016
1	Third Generation CephalosporinsIBA 02/2023
1	beta-Lactamase InhibitorsIBA 02/2023
1	First Generation CephalosporinsIBA 02/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	Cloxacillin (Tegopen)FDA Link 01/2023
1	Cefazolin (Ancef)FDA LinkGeneric 11/2022
1	Ertapenem (Invanz)FDA Link 11/2022
1	Amikacin (A.M.K)FDA LinkGeneric 11/2022
1	Ampicillin (Omnipen)FDA LinkGeneric 11/2022
1	Doxycycline (Periostat)FDA LinkGeneric 07/2022
1	Penicillins (Penicillin)FDA Link 07/2022
1	remdesivirIBA 01/2022

Therapy/Procedure

43	Therapeutics 01/2024 - 04/2008
13	Duration of Therapy 11/2023 - 12/2011
12	Critical Care (Surgical Intensive Care) 06/2023 - 06/2011
9	Length of Stay 02/2023 - 06/2011
8	Long-Term Care 11/2023 - 04/2013
8	Home Nursing (Nursing, Home) 01/2023 - 09/2017
8	Catheters 01/2023 - 01/2011
6	Artificial Respiration (Mechanical Ventilation) 04/2022 - 04/2015
5	Vascular Access Devices (Arterial Line) 01/2022 - 12/2011
3	Mechanical Ventilators (Ventilator) 05/2021 - 01/2021
3	Arthroplasty 11/2019 - 06/2009
2	Aftercare (After-Treatment) 09/2021 - 01/2016
2	Extracorporeal Membrane Oxygenation 01/2021 - 10/2016
2	Antibiotic Prophylaxis 01/2021 - 06/2011
2	Patient Readmission 05/2012 - 10/2009
1	Ambulatory Care (Outpatient Care) 07/2023
1	Central Venous Catheters 06/2023
1	Activities of Daily Living (ADL) 01/2023
1	Colectomy 12/2021